SeqWright

SeqWright is a genomic technology contract research organization that has been making waves in the industry since its establishment in 1994. The company, based in the United States, has a strong foothold in the Life Sciences sector and stands out with its CLIA certification and GLP compliance. With a commendable 17 years of expertise in genomics, SeqWright is known for its unwavering commitment to delivering customized and high-quality nucleic acid sequencing solutions. SeqWright's slogan is a testament to its forward-looking approach - "Pioneering the future of nucleic acid sequencing with over 17 years of unmatched quality and customized genomic solutions." The company's mission revolves around nurturing scientific and medical innovation by empowering and expediting the R&D initiatives of its clientele. Its willingness to tailor services to address individual customer needs sets it apart in a market characterized by rapid advancements and evolving demands. As of now, there is no publicly available information about SeqWright's latest investment or the involved investors. However, given its established presence, technical prowess, and alignment with the burgeoning field of genomics, SeqWright could pique the interest of venture capital firms seeking to tap into the promising landscape of nucleic acid sequencing and genomic solutions.